Understanding the Physiology of POTS
POTS is fundamentally a disorder of orthostatic compensation where multiple pathophysiological mechanisms—including autonomic denervation, hypovolemia, hyperadrenergic stimulation, and deconditioning—converge to produce excessive tachycardia as the body attempts to maintain blood pressure and cerebral perfusion when standing. 1
Core Pathophysiological Mechanisms
The physiology of POTS involves several distinct but often overlapping mechanisms that work together to create the clinical syndrome:
1. Autonomic Denervation (Neuropathic POTS)
Partial sympathetic denervation, particularly affecting the lower extremities, leads to inadequate vasoconstriction during standing. This results in excessive venous pooling—with calf venous volume increased by approximately 29% and venous filling times nearly doubled compared to healthy controls 2. The compensatory tachycardia attempts to maintain cardiac output when venous return is compromised.
2. Hypovolemia and Central Blood Volume Reduction
Many patients with POTS have reduced plasma volume and central blood volume. When standing, this baseline deficit is exacerbated by gravitational pooling, triggering baroreceptor-mediated tachycardia to defend cardiac output and blood pressure 1.
3. Hyperadrenergic State
Some patients exhibit excessive sympathetic activation with elevated standing norepinephrine levels. This hyperadrenergic response drives both the tachycardia and many associated symptoms like tremor, anxiety, and palpitations 3.
4. Deconditioning
Physical deconditioning reduces cardiac stroke volume and impairs skeletal muscle pump function, further compromising venous return during orthostasis. This creates a vicious cycle where symptoms limit activity, which worsens deconditioning 1, 4.
The Compensatory Nature of Tachycardia
A critical physiological insight is that the tachycardia in POTS is often compensatory rather than pathological. The heart rate increase represents an intact baroreflex attempting to maintain cardiac output when effective stroke volume or venous return is reduced 5. This is fundamentally different from primary autonomic failure where blood pressure cannot be defended.
During orthostasis, four cardiovascular parameters contribute to maintaining blood pressure:
- Chronotropic function (heart rate)
- Inotropic function (contractility)
- Vascular resistance (arterial tone)
- Venous capacitance (venous pooling)
When one or more parameters are compromised, the others must compensate disproportionately—hence the excessive tachycardia 6.
Vascular and Endothelial Contributions
Contrary to expectations, patients with POTS demonstrate increased central arterial stiffness (pulse wave velocity 5.5 vs 4.8 m/s in controls), not decreased stiffness 2. Endothelial function measured by flow-mediated dilation remains preserved, suggesting the primary problem lies in venous and microvascular function rather than large artery endothelial dysfunction 2.
Important Physiological Distinctions
The guideline explicitly recommends against pathophysiological subtyping during initial diagnosis because these mechanisms frequently coexist within individual patients and current tools cannot reliably distinguish them 1. However, understanding that multiple mechanisms may be operative helps explain why treatment must address multiple targets.
Key Physiological Pitfalls to Avoid:
Transient tachycardia on initial standing (initial orthostatic hypotension response) is NOT POTS—the heart rate increase must be sustained throughout 10 minutes 1
Athletes with low resting heart rates (e.g., 55 bpm) who reach only 85 bpm standing do NOT have POTS—standing heart rate must reach at least 90 bpm in adults regardless of the increment 1
Asymptomatic orthostatic tachycardia detected by wearable monitors is NOT POTS—chronic orthostatic symptoms must be present 1
Clinical Implications of the Physiology
The heterogeneous pathophysiology explains why POTS affects approximately 0.1-1% of the population, predominantly females (>90%), with peak onset between ages 13-40 years 1, 7. The disorder often follows triggering events—infections, surgery, or pregnancy occur in up to 50% of cases—suggesting immune-mediated or inflammatory contributions to the underlying mechanisms 1, 3.
Importantly, POTS is not associated with increased mortality 1. The tachycardia, while distressing, represents a compensatory mechanism that successfully maintains blood pressure in most cases. This physiological understanding should guide treatment toward addressing the underlying orthostatic stressor (volume expansion, reconditioning, vasoconstriction) rather than simply suppressing heart rate 5.
The prognosis is variable but many patients improve with appropriate mechanism-directed treatment that addresses the specific pathophysiological contributors in each individual 1, 8.